| Authors: |
Herbert BM; Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA., Carson JL; Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ., Bertolet M; Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA., Alexander JH; Duke Clinical Research Institute, Duke University, Durham, NC., Goodman SG; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada., Fergusson DA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Ducrocq G; Université de Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), French Alliance for Cardiovascular Trials (FACT), Paris, France., Lopes RD; Duke Clinical Research Institute, Duke University, Durham, NC., Simon T; Sorbonne Université, Paris, France; Assistance Publique - Hospitaux de Paris (AP-HP), Service de Pharmacologie, Plateforme de Recherche, Clinique de l'Est Parisien, Hospital Saint Antoine, Paris, France; French Alliance for Cardiovascular Trials (FACT), Paris, France., Steg PG; French Alliance for Cardiovascular Trials (FACT), Paris, France; Université Paris-Cité, Paris, France., Hebert PC; Bruyere Health Research Institute, University of Ottawa, Ontario, Canada., Brooks MM; Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA. Electronic address: mbrooks@pitt.edu. |
